Elephas will collaborate with the Mayo Clinic Comprehensive Cancer Center to develop of oncology imaging diagnostics platform that will predict response to immunotherapy, the company announced today.

“We are excited to be working with Mayo Clinic, an organization that shares our commitment to improving outcomes for patients fighting cancer,” Elephas CEO Maneesh Arora said in a statement.

According to a release, the primary goal of the collaboration is to validate that the data generated from the platform can be used to predict response. Also, researchers will collaborate on translational research using Elephas’ proprietary instruments, which are essential components of the diagnostic platform.

The collaboration will be part of a multi-year research agreement.